scispace - formally typeset
Journal ArticleDOI

Effect of Early Treatment with Aqueous Suppressants on Ahmed Glaucoma Valve Implantation Outcomes

Reads0
Chats0
TLDR
Early aqueous suppressant treatment may improve AGV implantation outcomes in terms of IOP reduction, success rate, and hypertensive phase frequency.
About
This article is published in Ophthalmology.The article was published on 2014-09-01. It has received 77 citations till now. The article focuses on the topics: Glaucoma valve & Intraocular pressure.

read more

Citations
More filters
Journal ArticleDOI

Simplifying “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma

TL;DR: An appropriate use of medications/laser/surgery to achieve such a “Target” IOP range in POAG or PACG can maintain visual fields and quality of life, preventing Glaucoma blindness.
Journal ArticleDOI

Aqueous shunts for glaucoma

TL;DR: To assess the effectiveness and safety of aqueous shunts for reducing IOP in glaucoma compared with standard surgery, another type of aQueous shunt, or modification to the aqueously shunt procedure, 27 trials were included.
Journal ArticleDOI

Risk factors for the hypertensive phase after implantation of a glaucoma drainage device.

TL;DR: To investigate risk factors for the development of the hypertensive phase after implantation of the Ahmed glaucoma valve (AGV), a large number of patients with atypical vitreous haemorrhages were fitted with the AGV.
Journal ArticleDOI

Effect of mitomycin c and 5‐flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation

TL;DR: To examine the effect of mitomycin c and 5‐flurouracil on treatment outcomes following Ahmed glaucoma valve implantation, a large number of patients were referred for treatment with these drugs.
References
More filters
Journal ArticleDOI

Aqueous Humor in Glaucomatous Eyes Contains an Increased Level of TGF-β2

TL;DR: The present findings support the concept of the intraocular derivation of this cytokine and hypothesize that the increased level of TGF-β2 in the aqueous humor of POAG patients causes a decrease in the cellularity of the trabecular meshwork and promotes the buildup of excessive amounts of ECM materials that are characteristic of this disease and contribute to the increased resistance to aQueous outflow.
Journal ArticleDOI

Initial clinical experience with the Ahmed Glaucoma Valve implant.

TL;DR: Although the 12-month success with the Ahmed Glaucoma Valve implant is similar to that reported for other drainage devices, the complications associated with overfiltration in the immediate postoperative period appear to be less frequent than with other valved drainage devices.
Journal ArticleDOI

A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma.

TL;DR: In this article, the authors evaluated clinical outcomes and established the incidence and management of a hypertensive phase (defined as intraocular pressure [IOP] > 21 mmHg in the first 6 postoperative months) in patients with Ahmed glaucoma valve implant.
Journal ArticleDOI

Glaucoma drainage devices: a systematic literature review and current controversies.

TL;DR: This review provides a systematic review of the literature and outlines the current controversies involving different glaucoma drainage devices and their design, overall surgical success, and complications following glau coma drainage device insertion.
Journal ArticleDOI

Follow-up of the original cohort with the Ahmed glaucoma valve implant.

TL;DR: In this paper, the authors analyzed the long-term outcome of a cohort of 60 eyes from 60 patients in whom the Ahmed glaucoma valve was implanted, and found that most of the failures after 12 months of postoperative follow-up were because of corneal complications.
Related Papers (5)